Here are three details:
1. Because of the technology, patients have walked 50,000 miles in the EksoGT exoskeleton to date.
2. The technology is designed to help patients get back on their feet. Along with the company’s SmartAssist software, the exoskeleton supports re-learning correct step partners, weight shifting and mitigating compensatory behaviors.
3. The FDA cleared EksoGT for use with stroke and spinal cord injuries from L5 to C7.
More articles on devices and implants:
Medtronic nabs No. 43 on Management Top 250 list
Spineology welcomes 2 new board members
Nexxt Spine launches posterior cervical thoracic system: 3 insights
